Specifically, MYC amplification mediates the glutamine-related metabolic rewiring in breast cancers, that promotes the excessive uptake of glutamine by inducing the expression of glutamine transporters and glutamine-metabolizing enzymes (180). This evidence concerns the gene MYC and breast cancer.